Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
about
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryIs lipid signaling through cannabinoid 2 receptors part of a protective system?Beta-caryophyllene is a dietary cannabinoidCB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesModulation of cellular redox homeostasis by the endocannabinoid systemTherapeutic potential of monoacylglycerol lipase inhibitorsThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsDevelopmental origins of NAFLD: a womb with a clue.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisCB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.Cannabinoids as novel anti-inflammatory drugs.The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosisThe cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisCB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Endocannabinoids in liver disease.Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsSulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathyProtective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs.Endocannabinoid signaling at the periphery: 50 years after THC.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
P2860
Q24595633-81B54223-9775-4DDC-837C-9CAFD78DAAFBQ24633122-A462D659-3CD5-4FB3-AD69-E61B97048839Q24645478-79786729-56D0-4264-9D0C-70B3A05DBF21Q24649936-56259B28-B3C7-450A-8EF6-DBB9D07B429DQ26744211-0D599850-67B7-4B22-9849-493720E098C7Q26991513-E0DC7BBD-4AC1-44F0-986F-3EE79C5F2BFDQ27009466-29F4D2EE-C71D-46D1-AA1B-7AF4151EDD26Q30241940-3DC279F0-968E-4EA6-9519-9EF8ED94C7AFQ33464957-2BAA49C5-48FE-4EFB-BF4B-889504D7E938Q33488512-DD6A22DD-D8F3-4EB8-89B9-0EDC11DCAE1EQ33602403-B4A9BE38-9223-4355-9405-A882F6E12417Q33688381-A03D539B-8C92-4BF0-BA56-3C2333CCCDB0Q33712156-700B181C-E4B1-4492-88E4-6F841CE9549EQ33714587-8B44639D-41FF-4C21-BE0C-682154305068Q33745557-8B31A028-6FF7-418F-A867-46D30628F243Q33792047-22C0B3DD-CC92-4978-BE3E-3CB66AB32AC4Q33793559-3DCE5029-CA00-473A-9EF1-2200A86A375FQ33847549-5AB3918C-B274-42B9-826F-FE0099655864Q33920996-9B271441-4C7E-488F-972E-AD32BAAE7E9EQ33947213-49BC03EC-91F5-41E7-AF3D-50FDF29C576AQ33993080-D5BA25FD-D906-425D-9586-73218D55F235Q34069579-D667385B-2626-4E20-B450-0A54FC9DDBB3Q34098258-AEA94DCB-E56D-4546-8231-E33BB4BB3676Q34098271-10566CF4-6E2B-45F0-A231-050CADD8D24AQ34155467-D25EC257-4ED3-4117-B0C4-48E5B7BAEEA5Q34186015-7745930F-4C3B-4F29-915C-6A611762868FQ34471868-859DD81C-609D-4F5B-9898-F5F9E10C101EQ34655802-029A1C88-D2C4-4877-9C40-502BBA54819AQ34657057-9365CBB2-4D1F-4219-9ECD-88A5F0BA530FQ34664067-0B4E1FF7-78C7-46EA-961E-92C9BFF4FE8AQ34733645-3AD764C3-3CBB-4A70-923C-8FED5D6FA251Q34776919-ED969B51-7C9E-49B2-A3EC-3A8DBB4EAEC3Q34851941-C24C94F4-D31B-423F-A2C1-20695AC0571DQ35193292-B5A5704A-7BAB-48E5-9DCA-290A0D45EED1Q35231426-A083BA3A-0B51-433F-B7EF-DFF5418CD490Q35531807-8D01A21B-3F6D-4DDC-A116-652615CB48CCQ35572176-BDC0F2CF-AC24-40F7-BDBB-29DD6A5E4547Q35854652-783C0389-8938-4975-BF6E-F2C416A8F855Q36176486-2947D60C-DE28-4D5D-A12C-CAE71B78B1A6Q36176499-46188F1B-F2FC-4149-AACD-B195F75654B2
P2860
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@ast
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@en
type
label
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@ast
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@en
prefLabel
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@ast
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
@en
P2093
Anjum Jafri
George Kunos
György Haskó
Judith Harvey-White
Mohanraj Rajesh
Osama El-Assal
Sándor Bátkai
P2860
P304
P356
10.1096/FJ.06-7451COM
P407
P577
2007-02-27T00:00:00Z